General
Seqens meets Frances Arnold at DCAT
SEQENS was honored to meet Frances Arnold, 2018 Chimistry Nobel Prize, at DCAT for a Keynote conference.
Read moreNewsroom
General
Seqens meets Frances Arnold at DCAT
SEQENS was honored to meet Frances Arnold, 2018 Chimistry Nobel Prize, at DCAT for a Keynote conference.
Read more
General
Underutilization of Aspirin in Patients With Advanced Colorectal Polyps
Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk…
Read more
General
GenEvolution: awarded at the “Entrepreneur Prize” trophies of the Grand Paris Seine & Oise
On the evening of Tuesday, March 19, 2019, GenEvolution, based at the Porcheville Seqens site, received two awards: the Public Prize and the Innovation…
Read more
General
National Apprentice Week
National Apprentice Week (NAW) 2019 takes place from 4th-8th March and is coordinated by the National Apprenticeship Service. It is designed to celebrate…
Read more
In short
La Madeleine site visited by the CHEDE
On February 20, Louis, Jacob, Gaulay and Houzelot welcomed more than 70 people from CHEDE (Cycle de Hautes Études pour le Développement Économique) to our site in La Madeleine.
First, a round table was held to discuss the major projects and the future of the site, but also the applicable environmental regulations and their difficulties, then CHEDE visited our facilities.
SD-CSR
Seqens employees discover handball for the disabled
SEQENS employees have tried their hand at the Hand’Wheelchair, an initiative proposed by the UODL HandBall Tassin Brindas sports association SEQENS is an…
Read more
General / Partnership & Financial
Seqens prize for a PHD-thesis in synthetic organic chemistry
“SEQENS Prix d’excellence” will reward excellence in innovative synthetic chemistry for sustainable development. In 2019, the “Ile-de-France” Section of the French Chemical Society…
Read more
General
Porcheville obtained its GMP certificate
SEQENS R&D Center in Porcheville, France, confirms its status as a center of excellence On 21 January 2019, the French National Agency for…
Read more
General
Novacap becomes Seqens!
SEQENS: a new name for a global leader in pharmaceutical synthesis and specialty ingredients Novacap and all its activities unify their names into a…
Read more
In short
Novacap becomes Seqens!
SEQENS: a new name for a global leader in pharmaceutical synthesis and specialty ingredients.
Novacap and all its activities unify their names into a new one and become SEQENS.